mitapivat
mitapivat is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including PYRUKYND, AQVESME. Available dosage forms: tablet, film coated, kit.
Drug Details
- Generic Name
- mitapivat
- Brand Names
- PYRUKYND, AQVESME
- Application Number
- NDA216196
- Sponsor
- Agios Pharmaceuticals, Inc.
- NDC Codes
- 13
- Dosage Forms
- TABLET, FILM COATED, KIT
- Routes
- ORAL
- Active Ingredients
- MITAPIVAT
Indications and Usage
1 INDICATIONS AND USAGE PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. ( 1 )